lncRNA NORAD modulates STAT3/STAT1 balance and innate immune responses in human cells via interaction with STAT3

被引:1
|
作者
Argoetti, Amir [1 ]
Shalev, Dor [1 ]
Polyak, Galia [1 ]
Shima, Noa [1 ]
Biran, Hadas [2 ]
Lahav, Tamar [1 ]
Hashimshony, Tamar [1 ]
Mandel-Gutfreund, Yael [1 ,2 ]
机构
[1] Technion Israel Inst Technol, Fac Biol, Emerson Bldg, Haifa, Israel
[2] Technion Israel Inst Technol, Fac Comp Sci, Taub Bldg, Haifa, Israel
基金
以色列科学基金会;
关键词
LONG NONCODING RNA; EMBRYONIC STEM-CELLS; ANTIVIRAL RESPONSES; PLURIPOTENCY; ULTRAFAST; EVOLUTION; CHROMATIN; GRANULES; BINDING; DNA;
D O I
10.1038/s41467-025-55822-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Long non-coding RNAs (lncRNAs) are pivotal regulators of cellular processes. Here we reveal an interaction between the lncRNA NORAD, noted for its role in DNA stability, and the immune related transcription factor STAT3 in embryonic and differentiated human cells. Results from NORAD knockdown experiments implicate NORAD in facilitating STAT3 nuclear localization and suppressing antiviral gene activation. In NORAD-deficient cells, STAT3 remains cytoplasmic, allowing STAT1 to enhance antiviral activity. Analysis of RNA expression data from in vitro experiments and clinical samples demonstrates reduced NORAD upon viral infection. Additionally, evolutionary conservation analysis suggests that this regulatory function of NORAD is restricted to humans, potentially owing to the introduction of an Alu element in hominoids. Our findings thus suggest that NORAD functions as a modulator of STAT3-mediated immune suppression, adding to the understanding of lncRNAs in immune regulation and evolutionary adaptation in host defense mechanisms.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] STAT1/STAT3 Gain of Function and Mechanisms of Immune Dysregulation
    Kiykim, Ayca
    TURKISH JOURNAL OF IMMUNOLOGY, 2024, 12 : 47 - 52
  • [2] Redox Regulation of STAT1 and STAT3 Signaling
    Butturini, Elena
    de Prati, Alessandra Carcereri
    Mariotto, Sofia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 18
  • [3] STAT3 but Not STAT1 Is Required for Astrocyte Differentiation
    Hong, Seulgi
    Song, Mi-Ryoung
    PLOS ONE, 2014, 9 (01):
  • [4] Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells
    Kirito, K
    Nagashima, T
    Ozawa, K
    Komatsu, N
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) : 51 - 54
  • [5] Constitutive Activation of Stat1 and Stat3 in Primary Erythroleukemia Cells
    Keita Kirito
    Toshihiro Nagashima
    Keiya Ozawa
    Norio Komatsu
    International Journal of Hematology, 2002, 75 : 51 - 54
  • [6] Steering of carcinoma progression by the YIN/YANG interaction of STAT1/STAT3
    Friedrich, Karlheinz
    Dolznig, Helmut
    Han, Xiaonan
    Moriggl, Richard
    BIOSCIENCE TRENDS, 2017, 11 (01) : 1 - 8
  • [7] Potential roles of Stat1 and Stat3 in cellular transformation
    Bromberg, JF
    Darnell, JE
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 : 425 - 428
  • [8] STAT1 and STAT3 as intracellular regulators of vascular remodeling
    Wincewicz, Andrzej
    Sulkowska, Mariola
    Rutkowski, Ryszard
    Sulkowski, Stanislaw
    Musiatowicz, Boguslaw
    Hirnle, Tomasz
    Famulski, Waldemar
    Koda, Mariusz
    Sokol, Grzegorz
    Szarejko, Przemyslaw
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (04) : 267 - 271
  • [9] IL-10 ACTIVATES STAT1 AND STAT3
    WEBERNORDT, RM
    GREENLUND, AC
    MOORE, KW
    DARNELL, JE
    SCHREIER, RD
    FASEB JOURNAL, 1995, 9 (04): : A772 - A772
  • [10] CTFH CELLS AS DISCRIMINATOR BETWEEN PATIENTS WITH STAT1 AND STAT3 MUTATIONS
    Moens, Leen
    Schaballie, Heidi
    Frans, Glynis
    Bosch, Barbara
    Schrijvers, Rik
    Corveleyn, Anniek
    Bossuyt, Xavier
    Meyts, Isabelle
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 259 - 259